Previous 10 | Next 10 |
2023-07-23 12:00:31 ET Soon after Johnson & Johnson ( NYSE: JNJ ) topped expectations with its Q2 2023 results last week, Baird came up with a report indicating brighter days for MedTech, mainly due to accelerating medical procedure volumes and a waning COVID impact in China. ...
2023-07-06 09:31:03 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2023 Financial Results PR Newswire WARSAW, Ind. , July 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
2023-06-16 07:10:50 ET Wall Street’s trading week dividend activity encompassed increased payouts from Caterpillar ( CAT ) and Target ( NYSE: TGT ), as well as declarations from stocks such as U.S. Bancorp ( USB ) and Microsoft ( NASDAQ: MSFT ). Additionally, ...
2023-06-14 12:52:33 ET Summary Stryker reported solid Q1 2023 results, and near-term prospects are positive due to positive trends in procedure demand and hospital spend on capital products. Stryker is well-positioned to capitalize on fast-growing orthopedic surgical robot market....
2023-06-14 02:38:07 ET Summary The VanEck Morningstar Wide Moat ETF offers investors exposure to high quality businesses with sustainable competitive advantages and a track record of success. MOAT has outperformed the S&P 500 on a total return basis since its inception in 2012...
2023-06-06 12:25:12 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-06-04 12:00:08 ET Billions of dollars in sales across various MedTech markets will be at stake if there is a broader acceptance of weight loss drugs developed by Novo Nordisk ( NVO ) and Eli Lilly ( NYSE: LLY ), Morgan Stanley argued in a research note last week. Novo N...
2023-05-26 10:14:10 ET Summary ZBH exceeded expectations with significantly higher organic sales growth and an EPS of $1.89. I am positive about management's decision to raise full-year guidance to 6-7% ex-FX, as I believe it indicates underlying strength and improved macro dynami...
2023-05-24 07:54:00 ET The health tech industry is expected to grow significantly in the coming years. The industry is being driven by a number of factors, including: The […] For further details see: Why Health Tech Stocks are Lined up as Structural Leaders in the Coming Bull (SW...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...